In the hepatitis C virus (HCV)-related cohort, elevated levels of Periostin in the liver indicate an increased likelihood of adverse outcomes, such as hepatocellular carcinoma (HCC), in patients with liver fibrosis (GSE15654) (Fig. 4C and Fig. S4A). The gene discussed is POSTN; the disease is Hepatic fibrosis.